Journal article
Contemporary Role of Lymph Node Dissection in Genitourinary Cancers: Where Are We in 2023?
European urology oncology, Vol.7(3), pp.412-420
06/2024
DOI: 10.1016/j.euo.2023.10.028
PMID: 37980250
Abstract
Lymphadenectomy during surgery for genitourinary malignancies has varying benefits.
To review contemporary evidence on lymph node dissection in genitourinary cancers.
We performed a collaborative review to summarize current evidence supporting lymph node dissection in urothelial, prostate, kidney, penile, and testis cancers. We present the evidence on patient selection and recommended dissection templates, and highlight knowledge gaps and ongoing areas of investigation.
Lymph node dissection remains the reference standard for lymph node staging. Pathologic nodal stage informs prognosis and guides adjuvant treatment. Appropriate template and patient selection are paramount to optimize outcomes and capitalize on the selective therapeutic benefits.
Accurate staging with lymphadenectomy is contingent on appropriate template selection. The cumulative benefit will depend on judicious patient selection.
We performed a collaborative review by a diverse group of experts in urology. We reviewed current evidence on lymph node dissection.
Details
- Title: Subtitle
- Contemporary Role of Lymph Node Dissection in Genitourinary Cancers: Where Are We in 2023?
- Creators
- Amanda A Myers - The University of Texas MD Anderson Cancer CenterAlberto Briganti - IRCCS Ospedale San RaffaeleBradley Leibovich - Mayo Clinic in ArizonaSeth P Lerner - Baylor College of MedicineMarco Moschini - IRCCS Ospedale San RaffaeleMorgan Rouprêt - Sorbonne UniversitéShahrokh F Shariat - Comprehensive Cancer Center ViennaPhilippe E Spiess - Moffitt Cancer CenterArnulf Stenzl - University of TübingenSamir S Taneja - NYU Langone HealthKarim A Touijer - Memorial Sloan Kettering Cancer CenterAshish M Kamat - The University of Texas MD Anderson Cancer Center
- Resource Type
- Journal article
- Publication Details
- European urology oncology, Vol.7(3), pp.412-420
- DOI
- 10.1016/j.euo.2023.10.028
- PMID
- 37980250
- NLM abbreviation
- Eur Urol Oncol
- ISSN
- 2588-9311
- eISSN
- 2588-9311
- Language
- English
- Date published
- 06/2024
- Academic Unit
- Urology
- Record Identifier
- 9984934815602771
Metrics
3 Record Views